Sign in

Myeloproliferative neoplasms: trials that stopped early

Trials on Myeloproliferative neoplasms that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.

Stopped early

31 stopped trials give a reason in the registry, latest registry update first.

  1. Withdrawn

    Study of Select Combinations in Adults With Myelofibrosis

    Reason given in the registry

    “This study was cancelled before enrolling any patients for business related reasons.”

    Quoted unchanged from ClinicalTrials.gov; record updated 4 Mar 2021.

    Ended
    Apr 2024
    Phase
    Phase 1
    Run by
    Novartis Pharmaceuticals
    Registry record
    NCT04283526

Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.